CytoMed Therapeutics Holds Annual Shareholders Meeting
Ticker: GDTC · Form: 6-K · Filed: May 24, 2024 · CIK: 1873093
| Field | Detail |
|---|---|
| Company | Cytomed Therapeutics LTD (GDTC) |
| Form Type | 6-K |
| Filed Date | May 24, 2024 |
| Risk Level | low |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $90,000, $70,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, shareholder-meeting, foreign-private-issuer
TL;DR
CytoMed held its shareholder meeting May 15th, filing its 6-K.
AI Summary
CytoMed Therapeutics Limited held its Annual Shareholders Meeting on May 15, 2024, at 11:00 a.m. local time. The company is a foreign private issuer filing a Form 6-K report for the month of May 2024, indicating it will file annual reports under cover of Form 20-F.
Why It Matters
This filing confirms the company's adherence to reporting requirements and provides a date for a key corporate governance event.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- CytoMed Therapeutics Limited (company) — Registrant
- May 15, 2024 (date) — Annual Shareholders Meeting date
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report cover
FAQ
What is the exact date and time the Annual Shareholders Meeting was held?
The Annual Shareholders Meeting was held on May 15, 2024, at 11:00 a.m. local time.
What type of filing is this Form 6-K for?
This is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Which form will CytoMed Therapeutics Limited use for its annual reports?
CytoMed Therapeutics Limited will file annual reports under cover of Form 20-F.
What is the principal executive office address of CytoMed Therapeutics Limited?
The principal executive office is located at 1 Commonwealth Lane #08-22 Singapore 149544.
When was the company's former name changed?
The former company name, CytoMed Therapeutics Pte. Ltd., was changed on July 16, 2021.
Filing Stats: 1,705 words · 7 min read · ~6 pages · Grade level 8.5 · Accepted 2024-05-24 11:12:06
Key Financial Figures
- $90,000 — e payment of Directors’ fees of US$90,000 for the financial year ending December
- $70,000 — d payment of Directors’ fees of US$70,000 for the financial year ended December 3
Filing Documents
- form6-k.htm (6-K) — 81KB
- 0001493152-24-021281.txt ( ) — 82KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: May 24, 2024 CytoMed Therapeutics Limited By: /s/ CHOO Chee Kong Name: CHOO Chee Kong Title: Director and Chairman 6